![]() ![]() In addition, these therapies are used in emergency and surgical medicine. Plasma protein therapies, which include plasma-derived therapies and recombinant analogs, are used to treat chronic, life-threatening diseases including bleeding disorders, primary immune deficiencies, alpha-1 antitrypsin deficiency and certain rare neurological disorders. These include: the Alpha-1 Association, GBS/CIDP, Hemophilia Federation of America, the Immune Deficiency Foundation, the International Patient Organization for Primary Immunodeficiencies, National Hemophilia Foundation and Primary Immunodeficiency UK. Patient organizations representing users of plasma protein therapies have pledged their support and are working to promote the event via websites, newsletters, social media and outreach. Increase understanding about lifesaving plasma protein therapies and rare diseases.Recognize the contributions of plasma donors in saving and improving lives.Raise global awareness about source plasma collection.Annapolis, MD, OctoThe Plasma Protein Therapeutics Association (PPTA) and its member companies are sponsoring International Plasma Awareness Week, October 13-20, designed to:
0 Comments
Leave a Reply. |